Cargando…
Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512742/ https://www.ncbi.nlm.nih.gov/pubmed/35913648 http://dx.doi.org/10.1007/s11523-022-00904-y |
_version_ | 1784797898082353152 |
---|---|
author | Girgis, Suzette Lin, Shun Xin Wang Pillarisetti, Kodandaram Banerjee, Arnob Stephenson, Tara Ma, Xuewen Shetty, Shoba Yang, Tong-Yuan Hilder, Brandi W. Jiao, Qun Hanna, Brett Adams, Homer C. Sun, Yu-Nien Sharma, Amarnath Smit, Jennifer Infante, Jeffrey R. Goldberg, Jenna D. Elsayed, Yusri |
author_facet | Girgis, Suzette Lin, Shun Xin Wang Pillarisetti, Kodandaram Banerjee, Arnob Stephenson, Tara Ma, Xuewen Shetty, Shoba Yang, Tong-Yuan Hilder, Brandi W. Jiao, Qun Hanna, Brett Adams, Homer C. Sun, Yu-Nien Sharma, Amarnath Smit, Jennifer Infante, Jeffrey R. Goldberg, Jenna D. Elsayed, Yusri |
author_sort | Girgis, Suzette |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9512742 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-95127422022-09-28 Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma Girgis, Suzette Lin, Shun Xin Wang Pillarisetti, Kodandaram Banerjee, Arnob Stephenson, Tara Ma, Xuewen Shetty, Shoba Yang, Tong-Yuan Hilder, Brandi W. Jiao, Qun Hanna, Brett Adams, Homer C. Sun, Yu-Nien Sharma, Amarnath Smit, Jennifer Infante, Jeffrey R. Goldberg, Jenna D. Elsayed, Yusri Target Oncol Correction Springer International Publishing 2022-08-01 2022 /pmc/articles/PMC9512742/ /pubmed/35913648 http://dx.doi.org/10.1007/s11523-022-00904-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Correction Girgis, Suzette Lin, Shun Xin Wang Pillarisetti, Kodandaram Banerjee, Arnob Stephenson, Tara Ma, Xuewen Shetty, Shoba Yang, Tong-Yuan Hilder, Brandi W. Jiao, Qun Hanna, Brett Adams, Homer C. Sun, Yu-Nien Sharma, Amarnath Smit, Jennifer Infante, Jeffrey R. Goldberg, Jenna D. Elsayed, Yusri Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma |
title | Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma |
title_full | Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma |
title_fullStr | Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma |
title_full_unstemmed | Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma |
title_short | Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma |
title_sort | correction: translational modeling predicts efficacious therapeutic dosing range of teclistamab for multiple myeloma |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512742/ https://www.ncbi.nlm.nih.gov/pubmed/35913648 http://dx.doi.org/10.1007/s11523-022-00904-y |
work_keys_str_mv | AT girgissuzette correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma AT linshunxinwang correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma AT pillarisettikodandaram correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma AT banerjeearnob correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma AT stephensontara correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma AT maxuewen correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma AT shettyshoba correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma AT yangtongyuan correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma AT hilderbrandiw correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma AT jiaoqun correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma AT hannabrett correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma AT adamshomerc correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma AT sunyunien correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma AT sharmaamarnath correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma AT smitjennifer correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma AT infantejeffreyr correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma AT goldbergjennad correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma AT elsayedyusri correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma |